Robert Azelby - Apr 10, 2023 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC. (KDNY)

Role
Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Stock symbol
KDNY
Transactions as of
Apr 10, 2023
Transactions value $
$0
Form type
4
Date filed
4/12/2023, 04:59 PM
Previous filing
Nov 2, 2022
Next filing
Aug 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Stock Option (right to buy) Award $0 +28.2K $0.00 28.2K Apr 10, 2023 Common Stock 28.2K $21.60 Direct F1
transaction KDNY Restricted Stock (RSU)(Common Stock) Award $0 +7K $0.00 7K Apr 10, 2023 Common Stock 7K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option fully vests as to 1/36 of the total shares monthly beginning on May 10, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
F3 The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on April 10, 2024, until fully vested subject to the Reporting Person's provision of service to the Issuer on each vesting date.